Oxbow Advisors, LLC Amgen Inc Transaction History

Oxbow Advisors, LLC

$747 Million
Q2 2024

A detailed history of Oxbow Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Oxbow Advisors, LLC holds 1,108 shares of AMGN stock, worth $349,618. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,108

Previous 1,108 -0.0%

Holding current value

$349,618

Previous $315,000 9.84%

% of portfolio

0.05%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $80,661 - $97,368	300 Added 37.13%	1,108 $315,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $2,557 - $2,884	-10 Reduced 1.22%	808 $232,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $599,319 - $744,071	-2,741 Reduced 77.02%	818 $219,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $18,740 - $22,841	83 Added 2.39%	3,559 $860,000
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $85,886 - $109,128	-375 Reduced 9.74%	3,476 $912,000
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $111,556 - $125,815	497 Added 14.82%	3,851 $868,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $92,514 - $102,952	401 Added 13.58%	3,354 $816,000
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $16,006 - $17,707	73 Added 2.53%	2,953 $714,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $14,916 - $17,070	75 Added 2.67%	2,880 $648,000
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $231,374 - $271,083	1,090 Added 63.56%	2,805 $596,000
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $71,241 - $79,037	305 Added 21.63%	1,715 $418,000
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $13,846 - $16,991	70 Added 5.22%	1,410 $333,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $18,281 - $21,905	-105 Reduced 7.27%	1,340 $259,000
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $17,503 - $20,518	105 Added 7.84%	1,445 $266,000
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $9,264 - $10,444	-50 Reduced 3.6%	1,340 $278,000
Q1 2018 Apr 30, 2018	BUY	$169.43 - $198.0 $5,760 - $6,732	34 Added 2.51%	1,390 $237,000
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $11,984 - $13,389	71 Added 5.53%	1,356 $236,000
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $214,967 - $245,435	1,285	1,285 $240,000

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account

Oxbow Advisors, LLC Amgen Inc Transaction History